| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Development Officer | 400 | $2.01 | $804 | 52,592 | Aug 18, 2026 | Aug 20, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 38,584 | — | — | 52,992 | May 18, 2026 | May 20, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Development Officer | 404 | $1.92 | $776 | 14,408 | May 14, 2026 | May 18, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 94,946 | — | — | 94,946 | Mar 1, 2026 | Mar 3, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Development Officer | 471 | $1.63 | $768 | 14,812 | Feb 14, 2026 | Feb 18, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Development Officer | 403 | $2.24 | $903 | 15,283 | Nov 14, 2025 | Nov 18, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Development Officer | 403 | $1.39 | $560 | 15,686 | Aug 14, 2025 | Aug 18, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Development Officer | 403 | $1.14 | $459 | 16,089 | May 14, 2025 | May 16, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 78,078 | — | — | 78,078 | Mar 1, 2025 | Mar 4, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Development Officer | 469 | $5.42 | $2.5K | 16,492 | Feb 14, 2025 | Feb 19, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Development Officer | 402 | $7.92 | $3.2K | 16,961 | Nov 14, 2024 | Nov 18, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Development Officer | 402 | $7.02 | $2.8K | 17,363 | Aug 14, 2024 | Aug 16, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Development Officer | 402 | $8.36 | $3.4K | 17,765 | May 14, 2024 | May 16, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 45,045 | — | — | 45,045 | Mar 1, 2024 | Nov 27, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Development Officer | 468 | $3.40 | $1.6K | 18,167 | Feb 14, 2024 | Feb 16, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Medical Officer | 1,395 | $5.08 | $7.1K | 18,635 | Nov 14, 2023 | Nov 16, 2023 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,030 | — | — | 20,030 | Nov 14, 2022 | Nov 16, 2022 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,090 | — | — | 60,090 | Nov 14, 2022 | Nov 16, 2022 ↗ | View → |